Companies: 10,795·Total market cap: $144.5T
Twist Bioscience Corporation

Twist Bioscience Corporation

TWSTNASDAQHealthcare● Active
$70.04
+$0.82(+1.18%)
Market Cap$4.4B
P/E Ratio
52W High$80.5
52W Low$23.3
Overview

Twist Bioscience Corporation (TWST) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TWST · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.32twst eps ttm · twst earnings per shareEarnings history
PE Ratio (TTM)twst pe ratio ttm · twst price to earningsPE Ratio deep dive
Revenue (TTM)$409.5Mtwst revenue ttm · twst annual revenueFull revenue history
Dividend YieldNo Dividenddoes twst pay dividends · twst dividend yieldDividend history
Shares Outstanding59.8Mtwst shares outstanding · twst floatShares outstanding history
Next EarningsAug 3, 2026Est.twst earnings date · twst next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$376.6M▲ +20.32% YoY
202320242025
twist bioscience corporation revenue · twst revenue 2025
FY 2025Net Income-$77.7M▲ +62.79% YoY
202320242025
twist bioscience corporation net income · twst profit 2025
FY 2025EPS$-1.30▲ +63.89% YoY
202320242025
twst eps · twist bioscience corporation earnings per share 2025
TTM:Revenue: $409.5MNet Income: -$81.3MEPS: $-1.32View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy13 analystsis twst a buy · twst analyst rating
Strong Buy
0
Buy
11
Hold
1
Sell
1
Strong Sell
0
12-Month Price Target
$52.00Low
$70.04Current
$64.40Avg Target8.05% downside
$80.00High
twst price target · twst 12 month forecast

Total: 13 · Buy rate: 84.6%

The TWST analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $64.40, representing -8.05% downside from the current price of $70.04.

Stock Performance

Full History
1D+1.18%
1W+0.33%
1M+23.20%
3M+49.21%
YTD+120.81%
1Y+109.95%
5Y-33.30%

About Twist Bioscience Corporation

CEOEmily Marine Leproust
IPO DateOct 31, 2018
Employees923
CountryUS

Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthes…

what is twist bioscience corporation · twst stock overview · twist bioscience corporation company profile · who is twist bioscience corporation ceo · twst NASDAQ · twist bioscience corporation headquarters · twist bioscience corporation business segments

About Stock Overview & Key Data

Twist Bioscience Corporation (TWST) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Oct 31, 2018. As of the latest trading session, TWST stock price is $70.04, with a market capitalization of $4.4B. The stock has returned +109.95% over the past 12 months and +120.81% year-to-date.

According to 13 Wall Street analysts, the consensus rating for Twist Bioscience Corporation stock is Buy, with an average 12-month price target of $64.40. In fiscal year 2025, Twist Bioscience Corporation reported revenue of $376.6M and net income of -$77.7M. For detailed data — including Twist Bioscience Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Twist Bioscience Corporation (TWST) stock price is $70.04. The stock is traded on NASDAQ under the ticker symbol TWST. The 52-week range is $23.30 – $80.50.

TWST stock priceTWST quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice